Medical Information
United States

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.
Not a healthcare professional? Go to the patient or caregiver website.

NYVEPRIA Patient Counseling Information (pegfilgrastim-apgf)


Advise the patient to read the FDA-approved patient labeling (Patient Information and Instructions for Use).

Advise patients of the following risks and potential risks with NYVEPRIA:

  • Splenic rupture and splenomegaly
  • Acute Respiratory Distress Syndrome
  • Serious allergic reactions
  • Sickle cell crisis
  • Glomerulonephritis
  • Capillary Leak Syndrome
  • Aortitis

Instruct patients who self-administer NYVEPRIA using the single-dose prefilled syringe of the:

  • Importance of following the Instructions for Use.
  • Dangers of reusing syringes.
  • Importance of following local requirements for proper disposal of used syringes.

This product's label may have been updated. For full prescribing information, please visit

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event